Meanwhile, we found that ATG4B protein levels were aberrantly elevated in AML patient‐derived primary PBMCs, whereas PRMT1 levels were notably decreased and DNA damage was significantly increased (Figure 8E). The gene discussed is PRMT1; the disease is acute myeloid leukemia.